Kewaunee Scientific Reports on Shareholder Vote Matters
Ticker: KEQU · Form: 8-K · Filed: Aug 29, 2024 · CIK: 55529
| Field | Detail |
|---|---|
| Company | Kewaunee Scientific CORP /De/ (KEQU) |
| Form Type | 8-K |
| Filed Date | Aug 29, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $2.50 |
| Sentiment | neutral |
Sentiment: neutral
Topics: governance, shareholder-vote
TL;DR
Kewaunee Scientific held a shareholder vote on Aug 28th. Details filed today.
AI Summary
Kewaunee Scientific Corporation filed an 8-K on August 29, 2024, reporting on matters submitted to a vote of its security holders on August 28, 2024. The filing details the company's corporate information, including its incorporation in Delaware and principal executive offices in Statesville, North Carolina.
Why It Matters
This filing indicates that Kewaunee Scientific Corporation held a shareholder vote, which is a key governance event for publicly traded companies.
Risk Assessment
Risk Level: low — The filing is a routine 8-K reporting a shareholder vote, not indicating any immediate financial distress or significant operational changes.
Key Players & Entities
- Kewaunee Scientific Corporation (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- Statesville, North Carolina (location) — Principal executive offices
- August 28, 2024 (date) — Date of earliest event reported
- August 29, 2024 (date) — Filing date
FAQ
What specific matters were submitted to a vote of Kewaunee Scientific Corporation's security holders?
The filing states that matters were submitted to a vote of security holders, but the specific details of those matters are not provided in this excerpt.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on August 28, 2024.
Where are Kewaunee Scientific Corporation's principal executive offices located?
The principal executive offices are located at 2700 West Front Street, Statesville, North Carolina.
In which state is Kewaunee Scientific Corporation incorporated?
Kewaunee Scientific Corporation is incorporated in Delaware.
What is the IRS Employer Identification Number for Kewaunee Scientific Corporation?
The IRS Employer Identification Number is 38-0715562.
Filing Stats: 485 words · 2 min read · ~2 pages · Grade level 12.4 · Accepted 2024-08-29 16:07:30
Key Financial Figures
- $2.50 — ange on which registered Common Stock, $2.50 par value KEQU The Nasdaq Global Ma
Filing Documents
- d872907d8k.htm (8-K) — 28KB
- 0001193125-24-209910.txt ( ) — 143KB
- kequ-20240828.xsd (EX-101.SCH) — 3KB
- kequ-20240828_lab.xml (EX-101.LAB) — 17KB
- kequ-20240828_pre.xml (EX-101.PRE) — 11KB
- d872907d8k_htm.xml (XML) — 3KB
From the Filing
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 28, 2024 Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction of incorporation) (Commission File Number) (IRS. Employer Identification No.) 2700 West Front Street 28677 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: 704 - 873-7202 N/A (Former name or former address, if changed since last report.) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $2.50 par value KEQU The Nasdaq Global Market Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item5.07 Submission of Matters to a Vote of Security Holders. (a) and (b)On August 28, 2024, Kewaunee Scientific Corporation (the "Company") held its Annual Meeting of Shareholders (the "Annual Meeting"). At the Annual Meeting, the Company's shareholders voted on the matters set forth below. 1. The nominee named below was re-elected as a Class II director for a three-year term as follows: Name of Nominee For Withheld Non-Votes Mr. Keith M. Gehl 1,404,874 273,145 739,723 2. The appointment of the independent registered public accounting firm of Forvis Mazars, LLP as the Company's independent auditors for fiscal year 2025 was ratified as follows: For Against Abstained 2,414,204 2,479 1,059 3. The compensation of the Company's named executive officers was approved on an advisory basis as follows: For Against Abstained Non-Votes 1,440,693 3,005 234,321 739,723 Signature Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. (Registrant) Kewaunee Scientific Corporation Date: August 29, 2024 /s/ Donald T. Gardner III Donald T. Gardner III Vice President, Finance and Chief Financial Officer